To assess the prevalence of NKG2A+ and NKG2C+ biases across different cancer types, we measured the percentages of NKG2A+ and NKG2C+ CD8+ T cells in cancer types for which we had large numbers of patients with single-cell data. The gene discussed is KLRC1; the disease is cancer.